StonvexLoading…
StonvexStonvexStonvexCore line items from ESRT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $190.05M | $766.79M | $567.80M | $370.48M |
Operating Income | $29.46M | $135.65M | $100.24M | $60.91M |
Net Income | $3.00M | $72.98M | $40.81M | $27.16M |
EPS (Diluted) | $0.01 | $0.25 | $0.14 | $0.09 |
Total Assets | $4.41B | $4.47B | $4.11B | $4.08B |
Total Liabilities | $2.58B | $2.65B | $2.31B | $2.29B |
Cash & Equivalents | $68.82M | $132.66M | $154.11M | $94.64M |
Free Cash Flow OCF − CapEx | $50.72M | $50.55M | $58.76M | $-14.01M |
Shares Outstanding | 269.35M | 270.04M | 269.94M | 269.74M |